Table 5.
Guideline assessment according to the AGREE-II instrument.
| Author/Guideline organisation or society/year | Domain scores (%) |
Mean overall quality (maximum possible score = 7) | ||||||
|---|---|---|---|---|---|---|---|---|
| Scope and purpose | Stakeholder involvement | Rigour of development | Clarity and presentation | Applicability | Editorial independence | Mean domain scores (%) | ||
| AAOS 2021 [36] (knee) | 100.0 | 88.1 | 96.4 | 100.0 | 82.1 | 82.1 | 91.5 | 6.0 |
| VADoD 2020 [38] | 95.2 | 61.9 | 93.8 | 95.2 | 73.2 | 53.6 | 78.8 | 6.0 |
| Zhang 2020 [32] | 90.5 | 81.0 | 87.5 | 88.1 | 30.4 | 82.1 | 76.6 | 6.0 |
| ACR 2019 [3] | 97.6 | 92.9 | 94.6 | 100.0 | 37.5 | 75.0 | 82.9 | 6.0 |
| OARSI 2019 [4] | 96.1 | 74.3 | 100.0 | 95.3 | 68.9 | 81.7 | 86.1 | 6.0 |
| ESCEO 2019 [34] | 90.5 | 69.0 | 76.8 | 100.0 | 50.0 | 85.7 | 78.7 | 6.0 |
| ISR 2019 [29] | 30.7 | 78.0 | 54.8 | 89.0 | 33.0 | 12.8 | 49.7 | 3.5 |
| RACGP 2018 [37] | 100.0 | 98.0 | 84.0 | 79.9 | 87.2 | 82.3 | 88.6 | 6.2 |
| EULAR 2018 [28] (hand) | 90.0 | 88.9 | 100.0 | 97.6 | 85.3 | 93.2 | 92.5 | 5.6 |
| AAOS 2017 [35] (hip) | 56.0 | 78.5 | 65.2 | 84.0 | 78.9 | 99.0 | 77.1 | 4.6 |
| TLAR 2017 [30] | 58.0 | 78.2 | 88.3 | 28.3 | 36.2 | 32.2 | 53.5 | 3.0 |
| PANLAR 2016 [31] | 81.0 | 69.0 | 58.9 | 92.6 | 41.1 | 85.7 | 71.4 | 5.0 |
| NICE 2014 [39] | 86.1 | 44.2 | 99.0 | 100.0 | 70.6 | 50.1 | 75.0 | 5.8 |
| EULAR 2013 [27] (knee/hip) | 94.4 | 90.6 | 89.4 | 53.1 | 100.0 | 98.0 | 87.9 | 6.5 |
| MSR 2013 [33] | 20.0 | 18.8 | 12.0 | 67.1 | 30.2 | 65.0 | 35.5 | 4.0 |
| Median score (%, IQR) | 90.5 (58.0,96.1) | 78.2 (69.0,88.9) | 88.3 (65.2,96.4) | 92.6 (79.9100.0) | 68.9 (36.2,82.1) | 82.1 (53.6,85.7) | 78.7 (71.4,87.9) | 6.0 (4.6,6.0)_ |
Abbreviation:
AAOS: American Academy of Orthopaedic Surgeons.
ACR: American College of Rheumatology.
AGREE II: Appraisal of Guidelines Research and Evaluation II.
ESCEO: European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
EULAR: European League Against Rheumatism.
ISR: Italian Society for Rheumatology.
IQR: interquartile range.
NICE: National Institute for Health and Care Excellence.
MSR: Malaysian Society of Rheumatology.
OARSI: Osteoarthritis Research Society International.
PANLAR: Pan American League of Associations for Rheumatology.
RACGP: Royal Australasian College of General Practitioners.
TLAR: Turkish League Against Rheumatism.
VADoD: Department of Veterans Affairs and Department of Defence.